Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine® Pump, this wearable micro-infusion pump has already been launched in several European countries.

The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of Apomorphine to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical available on the market gives Parkinson’s patients greater independence in their day-to-day lives.

The D-mine Pump is used to administer Apomorphine in the advanced stage of Parkinson’s treatment. Simple handling, safety, and ease of use were the main aims
behind the development. The compact design is down to Sensile Medical’s special micro-rotation pump technology and is straightforward to use thanks to an intuitive menu interface.

Parkinson’s patients often have difficulty moving and appreciate the pump’s ease of use, such as the automatic dosing function, the lack of complicated flow rate calculations, and the intuitive menu system. Its integrated choice of languages and the full-text display on its colour screen make it easier to learn the ropes, while modern technologies such as data storage and individually adjustable basal rates support better treatment management. The D-mine Pump comes with a specially designed charging station and does not need any conventional batteries.

With its own pharmaceutical product of the Parkinson’s drug Apomorphine and its own medical device, EVER Pharma now offers a comprehensive treatment package. You can find more information at www.d-minecare.com.

At Pharmapack 2020 in Paris – Expo Porte de Versailles

Gerresheimer will present its sustainable and innovative packaging and administration solutions at the Pharmapack in Paris on 5-6 February at booth B60/B64 in hall 7.2.